At A Glance: COVID-19 Vaccines In EU And Great Britain
Same Four Vaccines Approved And Comirnaty Indication Extended In Both Jurisdictions
The EU and UK have approved the same COVID-19 vaccines but the review pathways have not always been the same.
You may also be interested in...
Thirteen of the 20 new active substances that were approved in the EU between January and April this year have also now received regulatory clearance in Great Britain, Pink Sheet analysis finds. New filing procedures have been in place there since 1 January.
The Pink Sheet's EU accelerated assessment tracker has been updated to include developments relating to experimental products from Atara, Calliditas, and Roche.
The outcomes of a handful of requests for accelerated assessment at the European Medicines Agency appear not yet to be in the public domain. In the meantime, there's been good for news for Atara's tab-cel and a switch to standard review for Nefecon from Calliditas.